ScholarIQanswers from OpenAlex
University of Nebraska at Omaha
InstitutionResearch output, impact & collaborations
University of Nebraska at Omaha is a institution indexed in ScholarIQ from OpenAlex.
What is known about University of Nebraska at Omaha?
ScholarIQrecord summary
University of Nebraska at Omaha is a research organisation in Omaha, US. OpenAlex records 22,737 works and 757,930 citations for it. 4,010 researchers list it as their most recent affiliation.
How many works does University of Nebraska at Omaha have?
ScholarIQindexed works
University of Nebraska at Omaha has 22,737 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does University of Nebraska at Omaha have?
ScholarIQcitation count
University of Nebraska at Omaha has 757,930 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at University of Nebraska at Omaha?
ScholarIQresearcher count
University of Nebraska at Omaha has 4,010 researchers in the ScholarIQ index.
What is the average h-index at University of Nebraska at Omaha?
ScholarIQavg h-index
University of Nebraska at Omaha has an average h-index of 62.5 in OpenAlex.
What is the ROR of University of Nebraska at Omaha?
ScholarIQror
The ROR for University of Nebraska at Omaha is on the source record.
What is the OpenAlex record for University of Nebraska at Omaha?
ScholarIQopenalex
The OpenAlex for University of Nebraska at Omaha is on the source record.
Who are the most-cited researchers behind University of Nebraska at Omaha?
ScholarIQtop researchers by citations
What are the most-cited papers on University of Nebraska at Omaha?
ScholarIQmost cited works
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Kathleen N. Moore, Nicoletta Colombo, Giovanni Scambia, Byoung‐Gie Kim, Ana Oaknin, Michael Friedländer, Alla Lisyanskaya, Anne Floquet, Alexandra Léary, Gabe S. Sonke, Charlie Gourley, Susana Banerjee, Amit M. Oza, Antonio González-Martı́n, Carol Aghajanian, William H. Bradley, Cara Mathews, Joyce F. Liu, Elizabeth Lowe, Ralph Bloomfield, Paul DiSilvestro
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
Robert L. Coleman, Gini F. Fleming, Mark F. Brady, Elizabeth M. Swisher, Karina Dahl Steffensen, Michael Friedländer, Aikou Okamoto, Kathleen N. Moore, Noa Ben-Baruch, Theresa L. Werner, Noelle Cloven, Ana Oaknin, Paul DiSilvestro, Mark A. Morgan, Joo‐Hyun Nam, Charles A. Leath, Shibani Nicum, Andrea R. Hagemann, Ramey D. Littell, David Cella, Sally Baron‐Hay, Jesús García-Donás, Mika Mizuno, Katherine M. Bell‐McGuinn, Danielle Sullivan, Bruce Allen Bach, Sudipta Bhattacharya, Christine K. Ratajczak, Peter Ansell, Minh H. Dinh, Carol Aghajanian, Michael A. Bookman
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
Kathleen N. Moore, Angeles Alvarez Secord, Melissa A. Geller, David S. Miller, Noelle Cloven, Gini F. Fleming, Andrea E. Wahner Hendrickson, Masoud Azodi, Paul DiSilvestro, Amit M. Oza, Mihaela Cristea, Jonathan S. Berek, John K. Chan, B.J. Rimel, Daniela Matei, Yong Li, Kaiming Sun, Katarina Luptakova, Ursula A. Matulonis, Bradley J. Monk
Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial
Paul DiSilvestro, Susana Banerjee, Nicoletta Colombo, Giovanni Scambia, Byoung‐Gie Kim, Ana Oaknin, Michael Friedländer, Alla Lisyanskaya, Anne Floquet, Alexandra Léary, Gabe S. Sonke, Charlie Gourley, Amit M. Oza, Antonio González-Martı́n, Carol Aghajanian, William H. Bradley, Cara Mathews, Joyce F. Liu, John McNamara, Elizabeth Lowe, Mei-Lin Ah-See, Kathleen N. Moore, on behalf of the SOLO1 Investigators
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer
Kathleen N. Moore, Antoine Angelergues, Gottfried E. Konecny, Yolanda García García, Susana Banerjee, Domenica Lorusso, Jung‐Yun Lee, John W. Moroney, Nicoletta Colombo, A. Roszak, Jacqueline M. Tromp, Tashanna Myers, Jeong‐Won Lee, Mario Beiner, Casey Cosgrove, David Cibula, Lainie P. Martin, Renaud Sabatier, Joseph Buscema, Purificación Estévez-García, Lan Coffman, Shibani Nicum, Linda Duska, Sandro Pignata, Fernando Gálvez, Yuemei Wang, Michael Method, Anna Berkenblit, Diana Bello Roufai, Toon Van Gorp
How much of the research on University of Nebraska at Omaha is open access?
ScholarIQopen access share
75%OPEN ACCESS